Cargando…
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634169/ https://www.ncbi.nlm.nih.gov/pubmed/34551506 http://dx.doi.org/10.3324/haematol.2021.279174 |
| _version_ | 1784608082174672896 |
|---|---|
| author | Roboz, Gail J. Döhner, Hartmut Pocock, Christopher Dombret, Hervé Ravandi, Farhad Jang, Jun Ho Selleslag, Dominik Mayer, Jiří Martens, Uwe M. Liesveld, Jane Bernal, Teresa Wang, Ming Chung Yu, Peiwen Shi, Ling Guo, Shien La Torre, Ignazia Skikne, Barry Dong, Qian Braverman, Julia Nehme, Salem Abi Beach, C. L. Wei, Andrew H. |
| author_facet | Roboz, Gail J. Döhner, Hartmut Pocock, Christopher Dombret, Hervé Ravandi, Farhad Jang, Jun Ho Selleslag, Dominik Mayer, Jiří Martens, Uwe M. Liesveld, Jane Bernal, Teresa Wang, Ming Chung Yu, Peiwen Shi, Ling Guo, Shien La Torre, Ignazia Skikne, Barry Dong, Qian Braverman, Julia Nehme, Salem Abi Beach, C. L. Wei, Andrew H. |
| author_sort | Roboz, Gail J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8634169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86341692021-12-17 Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial Roboz, Gail J. Döhner, Hartmut Pocock, Christopher Dombret, Hervé Ravandi, Farhad Jang, Jun Ho Selleslag, Dominik Mayer, Jiří Martens, Uwe M. Liesveld, Jane Bernal, Teresa Wang, Ming Chung Yu, Peiwen Shi, Ling Guo, Shien La Torre, Ignazia Skikne, Barry Dong, Qian Braverman, Julia Nehme, Salem Abi Beach, C. L. Wei, Andrew H. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-09-23 /pmc/articles/PMC8634169/ /pubmed/34551506 http://dx.doi.org/10.3324/haematol.2021.279174 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Roboz, Gail J. Döhner, Hartmut Pocock, Christopher Dombret, Hervé Ravandi, Farhad Jang, Jun Ho Selleslag, Dominik Mayer, Jiří Martens, Uwe M. Liesveld, Jane Bernal, Teresa Wang, Ming Chung Yu, Peiwen Shi, Ling Guo, Shien La Torre, Ignazia Skikne, Barry Dong, Qian Braverman, Julia Nehme, Salem Abi Beach, C. L. Wei, Andrew H. Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title | Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title_full | Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title_fullStr | Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title_full_unstemmed | Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title_short | Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial |
| title_sort | oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase iii, placebo-controlled quazar aml-001 trial |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634169/ https://www.ncbi.nlm.nih.gov/pubmed/34551506 http://dx.doi.org/10.3324/haematol.2021.279174 |
| work_keys_str_mv | AT robozgailj oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT dohnerhartmut oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT pocockchristopher oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT dombretherve oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT ravandifarhad oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT jangjunho oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT selleslagdominik oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT mayerjiri oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT martensuwem oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT liesveldjane oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT bernalteresa oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT wangmingchung oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT yupeiwen oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT shiling oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT guoshien oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT latorreignazia oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT skiknebarry oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT dongqian oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT bravermanjulia oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT nehmesalemabi oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT beachcl oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial AT weiandrewh oralazacitidinepreservesfavorableleveloffatigueandhealthrelatedqualityoflifeforpatientswithacutemyeloidleukemiainremissionresultsfromthephaseiiiplacebocontrolledquazaraml001trial |